These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 10075862)

  • 1. The effect of anti-gp39 treatment on the intestinal manifestations of acute murine graft-versus-host disease.
    Stüber E; von Freier A; Fölsch UR
    Clin Immunol; 1999 Mar; 90(3):334-9. PubMed ID: 10075862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tissue transglutaminase (transglutaminase type II) for the intestinal manifestations of murine semi-allogenic graft-versus-host disease.
    Stüber E; Noth R; Dirks M; Arendt T; Fölsch U
    J Autoimmun; 2002 Feb; 18(1):1-8. PubMed ID: 11869041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy.
    Stüber E; Büschenfeld A; von Freier A; Arendt T; Fölsch UR
    Gut; 1999 Aug; 45(2):229-35. PubMed ID: 10403735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of human CD40-Ig fusion protein in a murine model of acute graft-versus-host disease.
    Liu H; Mao N; Hou C; Li X; Shen B; Tang PH
    Chin Med J (Engl); 2001 Jul; 114(7):685-9. PubMed ID: 11780327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity.
    Müerköster S; Laman JD; Rocha M; Umansky V; Schirrmacher V
    Clin Cancer Res; 2000 May; 6(5):1988-96. PubMed ID: 10815924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of OX40-OX40L interactions in the intestinal manifestations of the murine acute graft-versus-host disease.
    Stüber E; Von Freier A; Marinescu D; Fölsch UR
    Gastroenterology; 1998 Nov; 115(5):1205-15. PubMed ID: 9797376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases.
    Huang CC; Lu YF; Wen SN; Hsieh WC; Lin YC; Liu MR; Chiang E; Chang CN; Lin RH
    Eur J Immunol; 2005 Jul; 35(7):2239-49. PubMed ID: 15948216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid lethality of hosts by interleukin-12 following H-2 compatible allogeneic bone marrow transplantation: Reminiscence of gut-associated acute graft-versus-host reaction.
    Schmitt M; Taniguchi M; Yoshida T; Miyahara Y; Gu X; Mukai K; Yagita H; Dohner H; Shiku H
    Int J Oncol; 2002 Oct; 21(4):795-801. PubMed ID: 12239618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
    Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
    J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease.
    Buhlmann JE; Gonzalez M; Ginther B; Panoskaltsis-Mortari A; Blazar BR; Greiner DL; Rossini AA; Flavell R; Noelle RJ
    J Immunol; 1999 Apr; 162(8):4373-6. PubMed ID: 10201970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reactions in the small intestine. III. The effects of allograft rejection and of graft-versus-host disease on epithelial cell kinetics.
    MacDonald TT; Ferguson A
    Cell Tissue Kinet; 1977 Jul; 10(4):301-12. PubMed ID: 18287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival.
    Yin D; Zhang L; Wang R; Radvanyi L; Haudenschild C; Fang Q; Kehry MR; Shi Y
    J Immunol; 1999 Oct; 163(8):4328-34. PubMed ID: 10510372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
    Georgantas RW; Bohana-Kashtan O; Civin CI
    Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
    Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
    J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of novel anti-human Fas antibody HFE7a on graft-versus-host disease model.
    Kuwahara H; Tani Y; Ogawa Y; Takaichi Y; Shiraishi A; Ohtsuki M
    Clin Immunol; 2001 Jun; 99(3):340-6. PubMed ID: 11358429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells.
    Kawamura H; Yagita H; Nisizawa T; Izumi N; Miyaji C; Vance RE; Raulet DH; Okumura K; Abo T
    Eur J Immunol; 2005 Aug; 35(8):2358-66. PubMed ID: 15997467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments.
    Miura N; Yamamoto M; Fukutake M; Ohtake N; Iizuka S; Ishige A; Sasaki H; Fukuda K; Yamamoto T; Hayakawa S
    Int Immunol; 2005 May; 17(5):513-22. PubMed ID: 15778290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.